RPG LifeScience.

{
  "main_header": {
    "sid": 456242,
    "name": "RPG LifeScience.",
    "stock_name": "RPG LifeScience.",
    "full_name": "RPG Life Sciences Ltd",
    "name_url": "stocks-analysis/rpg-lifescience",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,778.10",
    "chg": -72.1,
    "chgp": "-2.53%",
    "dir": -1,
    "prev_price": "2,850.20",
    "mcapval": "4,594.70 Cr",
    "mcap": "Small Cap",
    "scripcode": 532983,
    "symbol": "RPGLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE105J01010",
    "curr_date": "Jul 30, 04:04 PM",
    "curr_time": "16:28 PM",
    "last_traded_at": "Jul 30, 04:04 PM IST",
    "bse_nse_vol": "24.27 k",
    "exc_status": "Active",
    "traded_date": "Jul 30, 2026",
    "traded_date_str": "2026 07 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rpg-lifescience-456242-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4128622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_mojoScore_4128622.png",
        "date": "2026-07-30 10:10:03",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Are RPG Life Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rpg-life-sciences-ltd-latest-results-good-or-bad-4127135",
        "imagepath": "",
        "date": "2026-07-29 19:19:16",
        "description": "RPG Life Sciences Ltd reported its financial results for Q1 FY27, showcasing a notable performance characterized by several key metrics. The company achieved net sales of ₹195.69 crores, reflecting a year-over-year revenue growth of 15.85% and a sequential growth of 10.63% from the previous quarter. This marks an all-time high in net sales, indicating a strengthening position in both domestic and export markets, supported by a diversified product portfolio that includes formulations and APIs.\n\nThe net profit for the quarter stood at ₹30.76 crores, which represents a year-over-year increase of 17.00%. However, the sequential growth was more modest at 2.88%, highlighting a slight deceleration compared to the previous quarter's performance. The operating margin improved to 22.12%, the highest in seven quarters, reflecting effective cost management and operational efficiency. The return on equity was reported a..."
      },
      {
        "title": "RPG Life Sciences Ltd Reports Strong Quarterly Financial Turnaround",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-reports-strong-quarterly-financial-turnaround-4125934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_fintrenddot_4125934.png",
        "date": "2026-07-29 11:00:11",
        "description": "RPG Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, signalling a positive shift from a previously flat trend. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics including net sales, profit after tax, and operating margins, reflecting robust operational execution and strategic momentum."
      },
      {
        "title": "RPG Life Sciences Q1 FY27: Robust Revenue Growth Drives Profit Surge Despite Premium Valuation",
        "link": "https://www.marketsmojo.com/news/result-analysis/rpg-life-sciences-q1-fy27-robust-revenue-growth-drives-profit-surge-despite-premium-valuation-4125961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_quaterlyResult_4125961.png",
        "date": "2026-07-29 09:47:09",
        "description": "RPG Life Sciences Ltd., a mid-sized pharmaceutical manufacturer specialising in formulations and active pharmaceutical ingredients, delivered a strong performance in Q1 FY27, with net profit climbing 17.00% year-on-year to ₹30.76 crores. The Mumbai-based company, valued at ₹4,687.24 crores, demonstrated resilience with revenue growth accelerating to 15.85% YoY whilst maintaining healthy operating margins above 22%. The stock has responded positively to sustained operational momentum, though investors remain cautious about the company's premium valuation of 44 times trailing earnings."
      },
      {
        "title": "RPG Life Sciences Gains 2.38%: 6 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-gains-238-6-key-factors-driving-the-weeks-volatility-4121315",
        "imagepath": "",
        "date": "2026-07-26 12:01:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> New 52-week and all-time high intraday peaks above Rs.3,040</p>\n                    <p><strong>21 Jul:</strong> Stock gaps down 6.03% but hits new 52-week high of Rs.3,080.90 intraday</p>\n                    <p><strong>22 Jul:</strong> Moderate recovery with 1.31% gain amid Sensex decline</p>\n                    <p><strong>23 Jul:</strong> Sharp 3.43% decline on low volume</p>\n                    <p><strong>24 Jul:</strong> Slight rebound of 0.37% closes the week at Rs.2,913</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,845.30</div><..."
      },
      {
        "title": "When is the next results date for RPG Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-rpg-life-sciences-ltd-4116726",
        "imagepath": "",
        "date": "2026-07-22 23:17:22",
        "description": "The next results date for RPG Life Sciences Ltd is scheduled for July 28, 2026...."
      },
      {
        "title": "RPG Life Sciences Ltd Opens 6.03% Lower in Sharp Gap Down as Technicals Point to Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-opens-with-significant-gap-down-amid-market-concerns-4112714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_gapdown_4112714.png",
        "date": "2026-07-21 13:00:33",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts RPG Life Sciences Ltd to 52-Week High of Rs 3080.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-hits-new-52-week-high-at-rs30809-4112140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_priceRelatedfactors_4112140.png",
        "date": "2026-07-21 09:42:13",
        "description": "With a decisive intraday peak at Rs 3080.9 on 21 Jul 2026, RPG Life Sciences Ltd has surged to a fresh 52-week high, marking a 16.22% gain over the past year against the Sensex’s decline of 5.55%. This milestone underscores the stock’s robust price momentum and technical alignment amid a mixed broader market backdrop."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as RPG Life Sciences Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-hits-all-time-high-at-rs-308090-4112115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RPGLifeSciences_priceRelatedfactors_4112115.png",
        "date": "2026-07-21 09:34:15",
        "description": ""
      }
    ],
    "total": 409,
    "sid": "456242",
    "stock_news_url": "https://www.marketsmojo.com/news/rpg-life-sciences-456242"
  },
  "announcements": [
    {
      "details": "RPG Life Sciences Limited has submitted to the Exchange a copy of disclosure of Related Party Transactions for the half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Other General Purpose",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "RPG Life Sciences Limited has informed the Exchange regarding 'In terms of the Regulation 30 read with Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter and half year ended September 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Updates",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "RPG Life Sciences Limited has informed the Exchange regarding Board meeting held on October 30, 2019.",
      "source": "NSE",
      "caption": "RPG Life Sciences Limited - Outcome of Board Meeting",
      "datetime": "31-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "RPG Life Sciences Ltd has declared <strong>300%</strong> dividend, ex-date: 09 Jul 26",
          "dt": "2026-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

RPG Life Sciences Ltd is Rated Hold

2026-07-30 10:10:03

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Are RPG Life Sciences Ltd latest results good or bad?

2026-07-29 19:19:16

RPG Life Sciences Ltd reported its financial results for Q1 FY27, showcasing a notable performance characterized by several key metrics. The company achieved net sales of ₹195.69 crores, reflecting a year-over-year revenue growth of 15.85% and a sequential growth of 10.63% from the previous quarter. This marks an all-time high in net sales, indicating a strengthening position in both domestic and export markets, supported by a diversified product portfolio that includes formulations and APIs. The net profit for the quarter stood at ₹30.76 crores, which represents a year-over-year increase of 17.00%. However, the sequential growth was more modest at 2.88%, highlighting a slight deceleration compared to the previous quarter's performance. The operating margin improved to 22.12%, the highest in seven quarters, reflecting effective cost management and operational efficiency. The return on equity was reported a...

Read full news article

RPG Life Sciences Ltd Reports Strong Quarterly Financial Turnaround

2026-07-29 11:00:11

RPG Life Sciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended June 2026, signalling a positive shift from a previously flat trend. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics including net sales, profit after tax, and operating margins, reflecting robust operational execution and strategic momentum.

Read full news article

RPG Life Sciences Q1 FY27: Robust Revenue Growth Drives Profit Surge Despite Premium Valuation

2026-07-29 09:47:09

RPG Life Sciences Ltd., a mid-sized pharmaceutical manufacturer specialising in formulations and active pharmaceutical ingredients, delivered a strong performance in Q1 FY27, with net profit climbing 17.00% year-on-year to ₹30.76 crores. The Mumbai-based company, valued at ₹4,687.24 crores, demonstrated resilience with revenue growth accelerating to 15.85% YoY whilst maintaining healthy operating margins above 22%. The stock has responded positively to sustained operational momentum, though investors remain cautious about the company's premium valuation of 44 times trailing earnings.

Read full news article

RPG Life Sciences Gains 2.38%: 6 Key Factors Driving the Week’s Volatility

2026-07-26 12:01:53

Key Events This Week

20 Jul: New 52-week and all-time high intraday peaks above Rs.3,040

21 Jul: Stock gaps down 6.03% but hits new 52-week high of Rs.3,080.90 intraday

22 Jul: Moderate recovery with 1.31% gain amid Sensex decline

23 Jul: Sharp 3.43% decline on low volume

24 Jul: Slight rebound of 0.37% closes the week at Rs.2,913

Week Open

Rs.2,845.30

<...

Read full news article

When is the next results date for RPG Life Sciences Ltd?

2026-07-22 23:17:22

The next results date for RPG Life Sciences Ltd is scheduled for July 28, 2026....

Read full news article

RPG Life Sciences Ltd Opens 6.03% Lower in Sharp Gap Down as Technicals Point to Mixed Signals

2026-07-21 13:00:33

Read full news article

Broad-Based Technical Strength Lifts RPG Life Sciences Ltd to 52-Week High of Rs 3080.9

2026-07-21 09:42:13

With a decisive intraday peak at Rs 3080.9 on 21 Jul 2026, RPG Life Sciences Ltd has surged to a fresh 52-week high, marking a 16.22% gain over the past year against the Sensex’s decline of 5.55%. This milestone underscores the stock’s robust price momentum and technical alignment amid a mixed broader market backdrop.

Read full news article

Strong Momentum Meets Stretched Valuations as RPG Life Sciences Ltd Reaches All-Time High

2026-07-21 09:34:15

Read full news article

View All News